Corient Private Wealth LLC Raises Holdings in GE HealthCare Technologies Inc. $GEHC

Corient Private Wealth LLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 18.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 65,023 shares of the company’s stock after purchasing an additional 10,226 shares during the period. Corient Private Wealth LLC’s holdings in GE HealthCare Technologies were worth $5,309,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after purchasing an additional 267,058 shares in the last quarter. Auto Owners Insurance Co grew its stake in shares of GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after purchasing an additional 33,629,559 shares in the last quarter. Dodge & Cox increased its holdings in GE HealthCare Technologies by 13.4% in the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after buying an additional 3,693,918 shares during the last quarter. Capital Research Global Investors increased its holdings in GE HealthCare Technologies by 1.6% in the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after buying an additional 389,796 shares during the last quarter. Finally, State Street Corp raised its stake in GE HealthCare Technologies by 2.0% in the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after buying an additional 401,932 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

GEHC stock opened at $65.76 on Friday. The stock’s fifty day simple moving average is $64.51 and its 200-day simple moving average is $73.96. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 52-week low of $58.75 and a 52-week high of $89.77. The stock has a market capitalization of $29.91 billion, a price-to-earnings ratio of 15.73, a price-to-earnings-growth ratio of 1.77 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The firm had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the business earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Insider Transactions at GE HealthCare Technologies

In other news, insider Frank R. Jimenez purchased 1,750 shares of the stock in a transaction that occurred on Thursday, April 30th. The stock was acquired at an average cost of $60.45 per share, with a total value of $105,787.50. Following the acquisition, the insider owned 93,932 shares in the company, valued at approximately $5,678,189.40. This trade represents a 1.90% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Rodney F. Hochman purchased 1,618 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were purchased at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the purchase, the director directly owned 1,618 shares in the company, valued at $100,364.54. This trade represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have bought 21,847 shares of company stock worth $1,361,355 over the last 90 days. 0.36% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

GEHC has been the subject of several recent analyst reports. Oppenheimer restated an “outperform” rating and set a $85.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and cut their price objective for the stock from $75.00 to $69.00 in a report on Thursday, May 21st. Barclays lowered their target price on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a report on Thursday, April 30th. Argus cut their price target on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Tuesday, May 19th. Finally, Royal Bank Of Canada initiated coverage on shares of GE HealthCare Technologies in a research report on Tuesday. They issued an “outperform” rating and a $80.00 price target for the company. Ten research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $80.20.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.